Omnicell Announces Financial Results for First Quarter 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/3/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Omnicell (OMCL) Tops Q1 EPS by 17c, Revenues Beat; Offers FY21 EPS/Revenues Mid-Point Outlook Above Consensus, Offers 2Q Revs. View Above Est.
April 29, 2021 4:36 PM EDTOmnicell (NASDAQ: OMCL) reported Q1 EPS of $0.83, $0.17 better than the analyst estimate of $0.66. Revenue for the quarter came in at $251.84 million versus the consensus estimate of $246.7 million.
We delivered an exceptionally strong first quarter, exceeding our first quarter guidance and achieving record revenue for the quarter, said Randall Lipps, Chairman, President, Chief Executive Officer, and founder of Omnicell. We continue to make tremendous progress advancing the vision of the autonomous pharmacy, and we continue to see robust and growing demand for our... More
